CLINICAL_TRIALS
trial_result
· 2016-04-28
Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 [Phase 1]
Summary
Phase 1 study of HMPL-523 in rheumatoid arthritis has completed, assessing safety, tolerability, and pharmacokinetics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hutchison Medipharma Limited | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: COMPLETED